GenVec, Inc.
(NASDAQ : GNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc.
0.07%55.210.6%$795.38m
JNJJohnson & Johnson
-0.63%137.990.6%$674.63m
ABBVAbbVie, Inc.
-0.90%93.622.1%$574.69m
PFEPfizer Inc.
-0.56%35.360.8%$547.67m
BMYBristol-Myers Squibb Company
-0.91%61.311.4%$343.78m
LLYEli Lilly and Company
-0.62%82.921.0%$273.08m
GSKGlaxoSmithKline plc Sponsored ADR
-0.38%35.060.2%$240.04m
NVSNovartis AG Sponsored ADR
1.13%83.960.2%$199.03m
AZNAstraZeneca PLC Sponsored ADR
-0.24%33.441.3%$108.49m
NVONovo Nordisk A/S Sponsored ADR Class B
0.80%50.910.1%$88.43m
SNYSanofi Sponsored ADR
-0.24%44.550.2%$62.16m
LCILannett Company, Inc.
0.00%23.9538.2%$17.13m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.93%10.5514.4%$4.77m
AKTXAkari Therapeutics Plc Sponsored ADR
6.16%4.652.2%$0.95m
EPIXESSA Pharma Inc
0.00%0.270.0%$0.04m

Company Profile

GenVec, Inc. is a clinical-stage gene delivery company, which engages in the development of therapeutics and vaccines. The firm designs, tests, and manufactures adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products include CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and is headquartered in Gaithersburg, MD.